Akebia Therapeutics executives hold one-on-one investor meetings at Virtual U.S. Bancorp I BTIG Kidney Health Forum
Bitget2026/10/07 12:01Akebia Therapeutics executives will hold one-on-one investor meetings at the Virtual U.S. Bancorp | BTIG Kidney Health Forum on Oct. 14, 2026. Discussions will cover its commercial products, plus clinical-stage pipeline programs for rare kidney diseases. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070800PRIMZONEFULLFEED9841307) on October 07, 2026, and is solely responsible for the information contained therein.
- Akebia Therapeutics executives will hold one-on-one investor meetings at the Virtual U.S. Bancorp | BTIG Kidney Health Forum on Oct. 14, 2026.
- Discussions will cover its commercial products, plus clinical-stage pipeline programs for rare kidney diseases.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Incap targets organic revenue growth to EUR 400 million by 2029
Insurance company Core Specialty Insurance (CORE.US) applies for US IPO, aiming to raise up to 250 million dollars
U.S. insurance company Core Specialty Insurance Holdings submitted an initial public offering (IPO) application to the Securities and Exchange Commission (SEC) on Monday, with the fundraising amount expected to reach up to $250 millions.

South Korean stocks closed down 2.59%

Acquisition brings incremental funding! Citi raises Bumble (BMBL.US) target price to $6.05, optimistic about Bumble 2.0 and new management team accelerating transformation
Citi released a research report, significantly raising the target price of dating platform Bumble from $3.20 to $6.05 to reflect the acquisition agreement by Ithaca Holdings, while maintaining a "Neutral" (High Risk) rating.